Dec 17, 2024 8:00am EST Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia
Dec 9, 2024 7:30am EST Tonix's TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
Dec 3, 2024 12:00 pm EST NobleCon20, Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference
